Essentra to showcase Patient Adherence solutions at Pharmapack
02 Feb 2017
Layers of security solutions are becoming increasingly important, with the EU Falsified Medicines Directive stating that all pharmaceutical companies providing medicines for human consumption will need to include a unique identifier and anti-tamper devices across all packaging, commencing February 2019.
Demonstrating their capabilities across tamper verification, authentication and serialisation features, Essentra is leading the industry in packaging that increases patient adherence.
